{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:34Z","timestamp":1787019574112,"version":"build-2736575974"},"reference-count":31,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,9]]},"DOI":"10.1182\/bloodadvances.2025016107","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T15:59:35Z","timestamp":1749139175000},"page":"4472-4476","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6503-4418","authenticated-orcid":false,"given":"Soravis","family":"Osataphan","sequence":"first","affiliation":[{"name":"1Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"},{"name":"2Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8426-3398","authenticated-orcid":false,"given":"Rushad","family":"Patell","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8420-4796","authenticated-orcid":false,"given":"Mrigya","family":"Babuta","sequence":"additional","affiliation":[{"name":"3Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"},{"name":"4Department of Animal Biology, School of Life Sciences, University of Hyderabad, Hyderabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2392-7365","authenticated-orcid":false,"given":"Rachel P.","family":"Rosovsky","sequence":"additional","affiliation":[{"name":"5Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9157-0524","authenticated-orcid":false,"given":"Yohei","family":"Hisada","sequence":"additional","affiliation":[{"name":"6UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6086-1674","authenticated-orcid":false,"given":"Charly","family":"Edmiston","sequence":"additional","affiliation":[{"name":"7Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-8095","authenticated-orcid":false,"given":"Pavania","family":"Elavalakanar","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1758-5442","authenticated-orcid":false,"given":"Michael A.","family":"Pfeffer","sequence":"additional","affiliation":[{"name":"5Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-1573","authenticated-orcid":false,"given":"Amy","family":"Bregar","sequence":"additional","affiliation":[{"name":"8Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ramos","sequence":"additional","affiliation":[{"name":"8Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA"},{"name":"9Division of Gynecology, Department of Surgery, Lahey Hospital and Medical Center, Burlington, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-909X","authenticated-orcid":false,"given":"Leslie","family":"Garrett","sequence":"additional","affiliation":[{"name":"10Division of Gynecologic Oncology, Department of Obstetric and Gynecology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyang","family":"Ren","sequence":"additional","affiliation":[{"name":"11Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2566-3145","authenticated-orcid":false,"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[{"name":"11Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-2527","authenticated-orcid":false,"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[{"name":"3Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8004-9688","authenticated-orcid":false,"given":"Robert","family":"Flaumenhaft","sequence":"additional","affiliation":[{"name":"1Division of Hematology and Hematologic Malignancies, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-7700","authenticated-orcid":false,"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[{"name":"6UNC Blood Research Center, Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7419-6654","authenticated-orcid":false,"given":"Meghan","family":"Shea","sequence":"additional","affiliation":[{"name":"2Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5810-6893","authenticated-orcid":false,"given":"Jeffrey I.","family":"Zwicker","sequence":"additional","affiliation":[{"name":"12Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"13Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"3","key":"2025090909364174300_bib1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"16","key":"2025090909364174300_bib2","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1200\/JCO.2008.16.1109","article-title":"Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum\/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group","volume":"26","author":"Fotopoulou","year":"2008","journal-title":"J Clin Oncol"},{"issue":"6","key":"2025090909364174300_bib3","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/IGC.0000000000000164","article-title":"Venous thromboembolism in advanced ovarian cancer patients undergoing frontline adjuvant chemotherapy","volume":"24","author":"Pant","year":"2014","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2025090909364174300_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"issue":"16","key":"2025090909364174300_bib5","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"issue":"6","key":"2025090909364174300_bib6","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/ATVBAHA.123.318779","article-title":"Updates in the incidence, pathogenesis, and management of cancer and venous thromboembolism","volume":"43","author":"Girardi","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"2025090909364174300_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/bjh.12163","article-title":"Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)","volume":"160","author":"Zwicker","year":"2013","journal-title":"Br J Haematol"},{"issue":"13","key":"2025090909364174300_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2025090909364174300_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/clc.21017","article-title":"Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy","volume":"35","author":"Huang","year":"2012","journal-title":"Clin Cardiol"},{"issue":"2","key":"2025090909364174300_bib10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1172\/JCI58969","article-title":"Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin","volume":"122","author":"Owens","year":"2012","journal-title":"J Clin Invest"},{"issue":"21","key":"2025090909364174300_bib11","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"21","key":"2025090909364174300_bib12","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"2025090909364174300_bib13","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/s41598-019-52366-4","article-title":"A novel semiconductor-based flow cytometer with enhanced light-scatter sensitivity for the analysis of biological nanoparticles","volume":"9","author":"Brittain","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"2025090909364174300_bib14","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1002\/hep.30766","article-title":"Dysregulated autophagy and lysosome function are linked to exosome production by micro-RNA 155 in alcoholic liver disease","volume":"70","author":"Babuta","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"2025090909364174300_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/rth2.12165","article-title":"Measurement of tissue factor activity in extracellular vesicles from human plasma samples","volume":"3","author":"Hisada","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"2025090909364174300_bib16","doi-asserted-by":"crossref","first-page":"b4583","DOI":"10.1136\/bmj.b4583","article-title":"Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study","volume":"339","author":"Sweetland","year":"2009","journal-title":"BMJ"},{"issue":"2","key":"2025090909364174300_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jtha.2022.11.017","article-title":"Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis","volume":"21","author":"Wiegers","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2025090909364174300_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jss.2003.07.001","article-title":"Increased platelet aggregation and production of platelet-derived microparticles after surgery for upper gastrointestinal malignancy","volume":"115","author":"Ikeda","year":"2003","journal-title":"J Surg Res"},{"key":"2025090909364174300_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2022.09.011","article-title":"Annexin V\u2013 and tissue factor+ microparticles as biomarkers for predicting deep vein thrombosis in patients after joint arthroplasty","volume":"536","author":"Chen","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2025090909364174300_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jtcvs.2015.05.069","article-title":"Circulating microparticles from patients with valvular heart disease and cardiac surgery inhibit endothelium-dependent vasodilation","volume":"150","author":"Fu","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"2025090909364174300_bib21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41598-018-19889-8","article-title":"Tissue factor-bearing MPs and the risk of venous thrombosis in cancer patients: a meta-analysis","volume":"8","author":"Cui","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"2025090909364174300_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41416-022-01968-3","article-title":"Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications","volume":"127","author":"Koizume","year":"2022","journal-title":"Br J Cancer"},{"issue":"8","key":"2025090909364174300_bib23","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3390\/ijms22083839","article-title":"Comparative analysis of platelet-derived extracellular vesicles using flow cytometry and nanoparticle tracking analysis","volume":"22","author":"George","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2025090909364174300_bib24","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/jth.12602","article-title":"Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing","volume":"12","author":"van der Pol","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2025090909364174300_bib25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nano.2015.12.370","article-title":"Enumeration of extracellular vesicles by a new improved flow cytometric method is comparable to fluorescence mode nanoparticle tracking analysis","volume":"12","author":"Pasalic","year":"2016","journal-title":"Nanomedicine"},{"issue":"10","key":"2025090909364174300_bib26","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.jtha.2024.05.037","article-title":"Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology","volume":"22","author":"Bonifay","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"5","key":"2025090909364174300_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MOH.0000000000000730","article-title":"Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods","volume":"29","author":"Mackman","year":"2022","journal-title":"Curr Opin Hematol"},{"issue":"2","key":"2025090909364174300_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jcb.30363","article-title":"How statin drugs affect exosomes?","volume":"124","author":"Sekhavati","year":"2023","journal-title":"J Cell Biochem"},{"issue":"2","key":"2025090909364174300_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jth.14364","article-title":"Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial","volume":"17","author":"Orsi","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2025090909364174300_bib30","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/jth.15626","article-title":"Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: a randomized controlled trial","volume":"20","author":"Ramberg","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"6","key":"2025090909364174300_bib31","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/jth.14004","article-title":"Effect of rosuvastatin on risk markers for venous thromboembolism in cancer","volume":"16","author":"Ades","year":"2018","journal-title":"J Thromb Haemost"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/17\/4472\/2410017\/blooda_adv-2025-016107-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/17\/4472\/2410017\/blooda_adv-2025-016107-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:36:50Z","timestamp":1757425010000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/17\/4472\/537626\/The-efficacy-of-rosuvastatin-to-reduce-circulating"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":31,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016107","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9,9]]},"published":{"date-parts":[[2025,8,29]]}}}